Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 51, 6202-6205, November 15, 1991]
© 1991 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ohgaki, H.
Right arrow Articles by Kleihues, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohgaki, H.
Right arrow Articles by Kleihues, P.

p53 Mutations in Nonastrocytic Human Brain Tumors1

Hiroko Ohgaki, Robert H. Eibl, Otmar D. Wiestler, M. Gazi Yasargil, Elizabeth W. Newcomb and Paul Kleihues2

Division of Neuropathology, Institute of Pathology [H. O., R. H. E., O. D. W., P. K.], and Department of Neurosurgery [M. G. Y.], University of Zurich, CH-8091 Zurich, Switzerland, and Department of Pathology and Kaplan Cancer Center, New York University Medical Center, New York, New York 10016 [E. W. N.]

Genomic DNA from 51 primary human brain tumors was screened for the presence of mutations in the tumor suppressor gene, p53, using the polymerase chain reaction and single strand conformation polymorphism analysis, followed by direct DNA sequencing. Mutations leading to an amino acid change were found in 2 of 17 (12%) oligodendrogliomas and 2 of 19 (11%) medulloblastomas but none of 15 ependymomas. Sites of mutations were in exon 5 (codon 141), exon 6 (codon 193 and 213), and exon 7 (codon 246). In addition, there were silent mutations in exon 6 (codon 213) in one oligodendroglioma and in one ependymoma. This study points to the possible role of the p53 tumor suppressor gene in some central nervous system neoplasms of divergent histogenesis.

1 Supported by grants from the Swiss National Science Foundation and National Cancer Institute Grant CA 40533.

2 To whom requests for reprints should be addressed.

Received 8/22/91. Accepted 9/30/91.




This article has been cited by other articles:


Home page
Arch Otolaryngol Head Neck SurgHome page
H. T. Yip, R. Chopra, R. Chakrabarti, M. S. Veena, B. Ramamurthy, E. S. Srivatsan, and M. B. Wang
Cisplatin-Induced Growth Arrest of Head and Neck Cancer Cells Correlates With Increased Expression of p16 and p53.
Arch Otolaryngol Head Neck Surg, March 1, 2006; 132(3): 317 - 326.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
P. Shannon, N. Sabha, N. Lau, D. Kamnasaran, D. H. Gutmann, and A. Guha
Pathological and Molecular Progression of Astrocytomas in a GFAP:12V-Ha-Ras Mouse Astrocytoma Model
Am. J. Pathol., September 1, 2005; 167(3): 859 - 867.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
V P Collins
Brain tumours: classification and genes
J. Neurol. Neurosurg. Psychiatry, June 1, 2004; 75(suppl_2): ii2 - ii11.
[Full Text] [PDF]


Home page
Cancer Res.Home page
W. Q. Yang, D. Senger, H. Muzik, Z. Q. Shi, D. Johnson, P. M. A. Brasher, N. B. Rewcastle, M. Hamilton, J. Rutka, J. Wolff, et al.
Reovirus Prolongs Survival and Reduces the Frequency of Spinal and Leptomeningeal Metastases from Medulloblastoma
Cancer Res., June 15, 2003; 63(12): 3162 - 3172.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
W. A. Weiss, M. J. Burns, C. Hackett, K. Aldape, J. R. Hill, H. Kuriyama, N. Kuriyama, N. Milshteyn, T. Roberts, M. F. Wendland, et al.
Genetic Determinants of Malignancy in a Mouse Model for Oligodendroglioma
Cancer Res., April 1, 2003; 63(7): 1589 - 1595.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Mueller, C. Hartmann, A. Hoffmann, W. Lanksch, J. Kiwit, J. Tonn, J. Veelken, J. Schramm, M. Weller, O. D. Wiestler, et al.
Genetic Signature of Oligoastrocytomas Correlates with Tumor Location and Denotes Distinct Molecular Subsets
Am. J. Pathol., July 1, 2002; 161(1): 313 - 319.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. Del Valle, J. Gordon, S. Enam, S. Delbue, S. Croul, S. Abraham, S. Radhakrishnan, M. Assimakopoulou, C. D. Katsetos, and K. Khalili
Expression of Human Neurotropic Polyomavirus JCV Late Gene Product Agnoprotein in Human Medulloblastoma
J Natl Cancer Inst, February 20, 2002; 94(4): 267 - 273.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
L Del Valle, J Baehring, C Lorenzana, A Giordano, K Khalili, and S Croul
Expression of a human polyomavirus oncoprotein and tumour suppressor proteins in medulloblastomas
Mol. Pathol., October 1, 2001; 54(5): 331 - 337.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
D. Zagzag, D. C. Miller, E. Knopp, J.-P. Farmer, M. Lee, S. Biria, A. Pellicer, F. J. Epstein, and J. C. Allen
Primitive Neuroectodermal Tumors of the Brainstem: Investigation of Seven Cases
Pediatrics, November 1, 2000; 106(5): 1045 - 1053.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
H. Huang, B. M. Mahler-Araujo, A. Sankila, L. Chimelli, Y. Yonekawa, P. Kleihues, and H. Ohgaki
APC Mutations in Sporadic Medulloblastomas
Am. J. Pathol., February 1, 2000; 156(2): 433 - 437.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
C. Ebert, M. von Haken, B. Meyer-Puttlitz, O. D. Wiestler, G. Reifenberger, T. Pietsch, and A. von Deimling
Molecular Genetic Analysis of Ependymal Tumors : NF2 Mutations and Chromosome 22q Loss Occur Preferentially inIntramedullary Spinal Ependymomas
Am. J. Pathol., August 1, 1999; 155(2): 627 - 632.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
D. J. Brat, C. D. James, A. E. Jedlicka, D. C. Connolly, E. Chang, R. J. Castellani, M. Schmid, M. Schiller, D. A. Carson, and P. C. Burger
Molecular Genetic Alterations in Radiation-Induced Astrocytomas
Am. J. Pathol., May 1, 1999; 154(5): 1431 - 1438.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
M. Nozaki, M. Tada, H. Kobayashi, C.-L. Zhang, Y. Sawamura, H. Abe, N. Ishii, and E. G. Van Meir
Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression
Neuro-oncol, April 1, 1999; 1(2): 124 - 137.
[Abstract] [PDF]


Home page
Cancer Res.Home page
H. Salewski, T. A. Bayer, U. Eidhoff, U. Preuss, S. Weggen, and K. H. Scheidtmann
Increased Oncogenicity of Subclones of SV40 Large T-induced Neuroectodermal Tumor Cell Lines after Loss of Large T Expression and Concomitant Mutation in p53
Cancer Res., April 1, 1999; 59(8): 1980 - 1986.
[Abstract] [Full Text] [PDF]


Home page
INT J SURG PATHOLHome page
H.-K. Ng, M. Phil, K.-W. Lo, D. P. Huang, and W.-S. Poon
p53 in Low-grade Gliomas
International Journal of Surgical Pathology, January 1, 1994; 1(3): 163 - 170.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1991 by the American Association for Cancer Research.